Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-30 Purchase | 2023-04-03 4:05 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 2,300 | $7.2395 | $16,651 | 1,949,295 (Indirect) | View |
| 2023-03-28 Purchase | 2023-03-30 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 23,908 | $7.2441 | $173,192 | 1,946,995 (Indirect) | View |
| 2023-03-24 Purchase | 2023-03-28 4:05 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 3,466 | $7.2424 | $25,102 | 1,923,087 (Indirect) | View |
| 2023-03-17 Purchase | 2023-03-21 4:40 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 89,297 | $7.1325 | $636,915 | 1,919,621 (Indirect) | View |
| 2023-03-15 Purchase | 2023-03-17 4:10 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 92,941 | $7.1043 | $660,278 | 1,830,324 (Indirect) | View |
| 2023-03-10 Purchase | 2023-03-14 4:05 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 48,003 | $7.1555 | $343,485 | 1,737,383 (Indirect) | View |
| 2023-03-03 Purchase | 2023-03-07 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 1,000 | $7.245 | $7,245 | 1,689,380 (Indirect) | View |
| 2023-03-01 Purchase | 2023-03-03 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 23,478 | $7.2428 | $170,047 | 1,688,380 (Indirect) | View |
| 2023-02-23 Purchase | 2023-02-27 4:07 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 200 | $7.235 | $1,447 | 1,664,902 (Indirect) | View |
| 2023-02-06 Purchase(A) | 2023-02-17 4:19 pm | Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr | 5,714 | $7 | $39,998 | 22,679 (Direct) | View |
| 2023-02-06 Purchase(A) | 2023-02-17 4:17 pm | Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer | 14,285 | $7 | $99,995 | 49,933 (Direct) | View |
| 2023-02-13 Purchase | 2023-02-15 6:32 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 10,072 | $7.1972 | $72,490 | 1,664,702 (Indirect) | View |
| 2023-02-09 Purchase | 2023-02-13 4:04 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 400 | $7.25 | $2,900 | 1,654,630 (Indirect) | View |
| 2023-02-03 Purchase | 2023-02-09 4:36 pm | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 311,078 | $7.103 | $2,209,588 | 1,654,230 (Indirect) | View |
| 2023-02-06 Purchase | 2023-02-08 7:40 pm | Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Prime Partners LLC Longitude Prime Fund L.P. Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner | 1,714,285 | $7 | $11,999,995 | 5,144,212 (Indirect) | View |
| 2023-02-06 Purchase | 2023-02-08 7:32 pm | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 1,714,285 | $7 | $11,999,995 | 5,144,212 (Indirect) | View |
| 2023-02-06 Purchase | 2023-02-08 6:29 pm | Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.P. HEALY JAMES Katabi Maha Sofinnova Management X-A L.L.C. 10% Owner | 285,714 | $7 | $1,999,998 | 3,467,156 (Direct) | View |
| 2022-02-06 Purchase | 2023-02-08 4:05 pm | Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr | 5,714 | $7 | $39,998 | 22,679 (Direct) | View |
| 2022-02-06 Purchase | 2023-02-08 4:04 pm | Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer | 14,285 | $7 | $99,995 | 54,933 (Indirect Direct) | View |
| 2022-12-16 Sale | 2022-12-19 5:01 pm | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 2,212 | $19.49 | $43,116 | 62,622 (Direct) | View |
| 2022-12-12 Sale | 2022-12-14 4:08 pm | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 19,711 | $18.26 | $359,973 | 177,961 (Direct) | View |
| 2022-12-07 Sale | 2022-12-08 4:06 pm | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 494 | $16.47 | $8,136 | 26,821 (Direct) | View |
| 2022-11-17 Sale | 2022-11-21 4:08 pm | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 3,289 | $15.85 | $52,128 | 75,045 (Direct) | View |
| 2022-11-09 Sale | 2022-11-10 4:04 pm | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 494 | $16.54 | $8,171 | 27,315 (Direct) | View |
| 2022-10-18 Sale | 2022-10-20 4:37 pm | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 8,590 | $19.41 | $166,735 | 162,845 (Direct) | View |
| 2022-10-05 Sale | 2022-10-06 4:04 pm | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 988 | $21.64 | $21,380 | 27,809 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-10 Option Award | 2023-05-12 4:18 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:17 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | MORRISSEY MICHAEL Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:16 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | Morrison Scott W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:14 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | Katabi Maha Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:13 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | Hall Kimball Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:12 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-05-10 Option Award | 2023-05-12 4:11 pm | N/A 2033-05-09 | Vera Therapeutics Inc. | VERA | Cheng Andrew Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:14 pm | N/A 2033-02-14 | Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr | 90,000 | $0 | 90,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:12 pm | N/A 2033-02-14 | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:10 pm | N/A 2033-02-14 | Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:08 pm | N/A 2033-02-14 | Vera Therapeutics Inc. | VERA | Lin Celia Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:05 pm | N/A 2033-02-14 | Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO | 450,000 | $0 | 450,000 (Direct) | View |
Ownership | 2023-02-08 7:21 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Longitude Prime Partners LLC Longitude Prime Fund L.P. 10% Owner | 0 | $0 | 1,714,285 (Indirect) | View |
| 2022-12-16 Exercise | 2022-12-19 5:01 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 2,212 | $2.8968 | 62,622 (Direct) | View |
| 2022-12-16 Exercise | 2022-12-19 5:01 pm | N/A 2030-12-15 | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 2,212 | $0 | 62,622 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 4:08 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 18,633 | $11 | 177,961 (Direct) | View |
| 2022-12-13 Exercise | 2022-12-14 4:08 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 1,078 | $6.3728 | 177,961 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 4:08 pm | N/A 2031-05-12 | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 19,711 | $0 | 177,961 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:08 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 2,211 | $2.8968 | 75,045 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:08 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 1,078 | $6.3728 | 75,045 (Direct) | View |
| 2022-11-17 Exercise | 2022-11-21 4:08 pm | N/A 2030-03-31 | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 3,289 | $0 | 75,045 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-17 4:06 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO | 60,000 | $2.8968 | 1,134,031 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-17 4:06 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO | 5,153 | $2.3174 | 1,134,031 (Direct) | View |
| 2022-11-16 Exercise | 2022-11-17 4:06 pm | N/A 2030-01-15 | Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO | 65,153 | $0 | 1,134,031 (Direct) | View |
| 2022-10-18 Exercise | 2022-10-20 4:37 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 2,212 | $2.8968 | 162,845 (Direct) | View |
| 2022-10-18 Exercise | 2022-10-20 4:37 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 5,300 | $11 | 162,845 (Direct) | View |
| 2022-10-18 Exercise | 2022-10-20 4:37 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 1,078 | $6.3728 | 162,845 (Direct) | View |
| 2022-10-18 Exercise | 2022-10-20 4:37 pm | N/A 2030-03-31 | Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer | 8,590 | $0 | 162,845 (Direct) | View |